Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Metagenomi (MGX) Equity Average (2023 - 2025)

Metagenomi (MGX) has disclosed Equity Average for 3 consecutive years, with $168.5 million as the latest value for Q4 2025.

  • Quarterly Equity Average fell 31.3% to $168.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $168.5 million through Dec 2025, down 31.3% year-over-year, with the annual reading at $196.7 million for FY2025, 296.33% up from the prior year.
  • Equity Average for Q4 2025 was $168.5 million at Metagenomi, down from $187.1 million in the prior quarter.
  • The five-year high for Equity Average was $272.5 million in Q2 2024, with the low at -$96.3 million in Q2 2023.
  • Average Equity Average over 3 years is $129.0 million, with a median of $187.1 million recorded in 2025.
  • The sharpest move saw Equity Average soared 611.59% in 2024, then crashed 31.3% in 2025.
  • Over 3 years, Equity Average stood at -$67.9 million in 2023, then soared by 461.55% to $245.3 million in 2024, then tumbled by 31.3% to $168.5 million in 2025.
  • According to Business Quant data, Equity Average over the past three periods came in at $168.5 million, $187.1 million, and $204.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.